Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Celiac Disease Treatment Market Set To Climb From $0.72 Billion In 2026 To $1.02 Billion By 2030#_x000D_
The celiac disease treatment market has shown strong expansion in recent years. Its value is set to rise from $0.66 billion in 2025 to $0.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. Historically, this growth can be attributed to several factors including limited pharmacological treatment options, a reliance on gluten-free diet management, increasing diagnosis rates, greater awareness of autoimmune disorders, and improved availability of diagnostic testing._x000D_
_x000D_
The celiac disease treatment market size is anticipated to experience robust expansion over the forthcoming years. It is projected to reach $1.03 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is propelled by the development of non-dietary therapeutic options, the broadening of enzyme and immunotherapy pipelines, the increasing global prevalence of celiac disease, enhanced diagnostic accuracy, and increased healthcare spending on chronic autoimmune diseases. Significant trends expected during this period include the rising adoption of gluten-free dietary management, the ongoing development of enzyme-based therapies, an intensified focus on early diagnosis and screening, the expansion of nutritional supplement-based treatments, and greater patient awareness and disease education._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Celiac Disease Treatment Market Growth Factors Behind Sustained Expansion#_x000D_
The increasing incidence of diabetes is projected to fuel the expansion of the celiac disease treatment market moving forward. Diabetes is a long-term medical condition where the body struggles to properly regulate its blood sugar or glucose levels. The rising prevalence of diabetes is linked to shared dietary management requirements, as both diabetes and celiac disease necessitate strict control over food intake to manage blood sugar and prevent associated issues. Celiac disease treatment assists diabetes by promoting a gluten-free diet, which can enhance overall digestive wellness and nutrient uptake. This helps achieve better blood sugar management and reduces complications for individuals managing both health issues. For instance, in June 2024, the National Health Service, a UK-based government department, reported that roughly 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, showing an 18% increase from 3,065,825 cases in 2022. Therefore, the growing occurrence of diabetes is acting as a catalyst for the celiac disease treatment market’s growth._x000D_
_x000D_
#Celiac Disease Treatment Market Breakdown By Product Type And Application#_x000D_
The celiac disease treatment market covered in this report is segmented – _x000D_
_x000D_
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments _x000D_
2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy_x000D_
3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels_x000D_
_x000D_
Subsegments:_x000D_
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins _x000D_
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations _x000D_
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents _x000D_
4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies_x000D_
_x000D_
#Celiac Disease Treatment Market Industry Trends Fueling Future Revenue Growth#_x000D_
Major companies operating in the celiac disease treatment market are prioritizing the development of oral therapies, such as small molecule treatments, to offer targeted relief by blocking immune responses to gluten, enhance patient adherence, and provide alternatives to strict gluten-free diets. Small molecule therapies are minute drugs capable of easily entering cells to target and treat proteins or enzymes that cause disease. For instance, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule designed to increase endogenous glucagon-like peptide-1 (GLP-1) levels, which aids in improving intestinal barrier function in celiac disease patients. It also enhances nutrient absorption and alleviates symptoms without suppressing immune activity._x000D_
_x000D_
#Celiac Disease Treatment Market Company Landscape And Competitive Strategy#_x000D_
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX _x000D_
_x000D_
#View The Full Celiac Disease Treatment Market Report:#_x000D_
_x000D_
#Celiac Disease Treatment Market Top Region: Where Does Most Revenue Come From?#_x000D_
North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model